COVID-19 and Your Health

If the Food and Drug Administration (FDA) authorizes or approves a COVID-19 vaccine, ACIP will quickly hold a public meeting to review all available data about that vaccine (sign up to receive email updates whenever ACIP’s Meeting Information is updated). From these data, ACIP will then vote on whether to recommend the vaccine and, if so, who should receive it.

On December 1, 2020, ACIP made recommendations on who should be offered COVID-19 vaccination in the initial phase of the U.S. COVID-19 vaccination program while there is limited vaccine supply. ACIP will meet again after FDA has authorized or approved specific COVID-19 vaccines and will make recommendations for the use of individual vaccines at that time.